🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
The aims of this Study were to determine: * How much of the Study Drug (be...
Status
Completed
Location
Labcorp Clinical Research Unit Ltd.
Start Date
2022-08-02
Trial ID
NCT06469138
Treatments Being Tested
This study is being done to evaluate the safety of the investigational stud...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2016-11
Trial ID
NCT02922777
The purpose of the study is to assess the safety and efficacy of BGB324 giv...
Status
Completed
Location
Haukeland University Hospital
Start Date
2017-02-13
Trial ID
NCT02872259
Treatments Being Tested
This is an open-label, multi-center, single arm, phase II study to assess t...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center (DHMC)
Start Date
2017-10-02
Trial ID
NCT03184571
Treatments Being Tested
A Phase Ib/II multicentre open label study of bemcentinib (BGB324) as a sin...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2014-10-22
Trial ID
NCT02488408
Treatments Being Tested
This phase I trial studies how well AXL inhibitor BGB324 works in treating ...
Status
Terminated
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2020-01-02
Trial ID
NCT03965494
Treatments Being Tested
This is an open label, single arm, multi-centre phase II study to assess th...
Status
Terminated
Location
City of Hope Cancer Center
Start Date
2017-07-26
Trial ID
NCT03184558
Treatments Being Tested
MiST is a British Lung Foundation funded, University of Leicester Study, a ...
Status
Completed
Location
University Hospitals of Leicester NHS Trust
Start Date
2019-01-28
Trial ID
NCT03654833